Zai Lab (ZLAB) Total Non-Current Liabilities (2022 - 2026)

Zai Lab (ZLAB) posted Total Non-Current Liabilities of $433.7 million for Q1 2026, down 5.07% sequentially from $456.9 million in Q4 2025, and up 19.73% YoY from $362.3 million in Q1 2025.

Zai Lab (ZLAB) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends

Zai Lab has reported Total Non-Current Liabilities for 5 years, with the latest figure at $433.7 million in Q1 2026.

  • Quarterly Total Non-Current Liabilities rose 19.73% year-over-year to $433.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $433.7 million (up 19.73% YoY) and the FY2025 annual result came in at $456.9 million, up 32.61% from the prior year.
  • Total Non-Current Liabilities retreated to $433.7 million in Q1 2026 per ZLAB's latest filing, from $456.9 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $456.9 million in Q4 2025 and troughed at $162.4 million in Q3 2023.
  • A 5-year average of $293.8 million and a median of $300.1 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2024 and 2026: Total Non-Current Liabilities jumped 95.43% in 2024, then advanced 19.73% in 2026.
  • Over 5 years, Total Non-Current Liabilities stood at $174.5 million in 2022, then soared by 37.42% to $239.9 million in 2023, then surged by 43.64% to $344.5 million in 2024, then soared by 32.61% to $456.9 million in 2025, then fell by 5.07% to $433.7 million in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $433.7 million, $456.9 million, and $398.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 5.92 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 7.74 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 40.00 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 1.53 Bn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.88 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 9.32 Bn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 4.20 Bn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 1.17 Bn
10 Zai Lab 2.91 Bn 2.20 Bn 58.15 Mn 467.53 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 467.53 Mn
Mar 31, 2026 433.72 Mn
Dec 31, 2025 456.88 Mn
Sep 30, 2025 398.67 Mn
Jun 30, 2025 372.04 Mn
Mar 31, 2025 362.25 Mn
Dec 31, 2024 344.53 Mn
Sep 30, 2024 317.35 Mn
Jun 30, 2024 282.86 Mn
Mar 31, 2024 225.94 Mn
Dec 31, 2023 239.85 Mn
Sep 30, 2023 162.39 Mn
Jun 30, 2023 173.73 Mn
Mar 31, 2023 168.51 Mn
Dec 31, 2022 174.55 Mn